By Chris Storer, General Manager at JT Grosvenor
In speciality chemical manufacturing, fragmentation often creeps in gradually. From adhesives and cleaning products to crop protection solutions, operational complexity can increase as formulations move from development into commercial-scale production.
A business develops a product and demand begins to grow. As volumes increase, different parts of the production process may be allocated to separate providers: one for raw materials, another for formulation, another for manufacturing, with filling, packing, storage and distribution managed elsewhere. The problem is that every additional interface creates another point where information, specifications or accountability can be lost.
The resulting cost is not always visible in procurement figures. It can appear as longer lead times, duplicated quality checks, delays in implementing changes or more difficult investigations. For specialist chemical manufacturers, these issues can affect operational efficiency and production consistency.
As manufacturers face greater pressure to improve efficiency, resilience and speed to market, the structure of the production model itself is coming under greater scrutiny.
The operational impact of multiple handoffs
The challenge with fragmented production is not simply the number of suppliers involved, but the number of interfaces that have to function effectively for the final product to be as required. A specification change may need to be communicated from formulation through to raw material sourcing, manufacturing and packing. If that information is not communicated accurately and consistently, the risk of deviation increases.
The same applies to production delays. If one supplier cannot meet an agreed timeline, manufacturing capacity and packing schedules can be affected, leaving finished goods unavailable when required.
Quality investigations can also become more complex when responsibility is divided between organisations. Identifying the root cause may require information from several companies, each with different processes and levels of visibility.
These operational costs can be difficult to quantify but become increasingly significant as production volumes rise. For specialist manufacturers, the challenge is maintaining control as the product moves from development into commercial production. A formulation that performs successfully at development scale still needs to be manufactured consistently at volume, with appropriate process controls and reliable supply of raw materials.
A fragmented production model can make that transition more difficult because the knowledge required to manage the product is distributed across multiple organisations.
When fragmentation becomes a constraint
A fragmented model is not inherently ineffective. Specialist suppliers can provide valuable expertise and flexibility. The issue arises when the coordination required to manage those relationships begins to outweigh the benefits.
That point often comes as businesses scale, as production volumes and customer requirements increase.
For specialist SMEs, a model that works at low volume may not provide the same level of control as production increases. Lead times can become harder to manage, changes can take longer to implement and quality issues more difficult to resolve.
The question therefore becomes less about whether individual suppliers are performing effectively and more about whether the overall production system is functioning efficiently.
Why integrated manufacturing is gaining attention
These pressures are prompting manufacturers to reconsider how products move from formulation through to market.
An integrated approach brings key stages of the process closer together, with technical and operational activities coordinated through a more connected manufacturing model. This can potentially cover formulation, raw material sourcing, manufacturing, filling, packing and distribution. The objective is not necessarily to eliminate every external supplier, but to reduce unnecessary interfaces and improve control across the stages that have the greatest impact on quality, continuity and delivery.
With fewer organisational boundaries between critical activities, information can move directly between technical and operational teams. Changes to specifications or processes can be managed with greater visibility, while issues can be investigated using information from across the production process. This can be particularly valuable during scale-up.
Moving from development to commercial production introduces challenges that cannot always be addressed by simply increasing batch size. Process conditions, equipment, mixing behaviour, raw material variability and quality controls all need to be considered. The closer the relationship between formulation knowledge and manufacturing capability, the easier it can be to identify and manage these factors.
Integration as a resilience measure
A connected production model can improve resilience by giving businesses greater visibility over how changes in one part of the process affect the rest. If raw material availability changes, technical and manufacturing teams can assess the implications more quickly. If customer requirements change, the impact on formulation, production and packing can be considered together.
That does not remove supply chain risk. It can, however, reduce the time and coordination required to respond to it.
For liquid formulations and other specialist chemical products, maintaining consistency at commercial scale depends on controlling the process as well as the formulation itself. Reliable production therefore requires continuity between technical knowledge, manufacturing processes and quality systems.
A more connected route from concept to market
For manufacturers reassessing their production models, the key question is not whether fragmentation can be managed, but whether the additional interfaces it creates are generating avoidable cost and risk.
An integrated approach can reduce those interfaces and provide greater continuity between development, production and delivery. Fragmentation may remain appropriate for some businesses and products, but as production volumes and operational complexity increase, the cost of managing multiple disconnected stages can become harder to justify.
For specialist chemical manufacturers, the objective should be to maintain control from formulation through to commercial production and delivery. The more complex the product and the greater the pressure to scale, the more important continuity becomes.
Read other recent UK Manufacturing news: https://uk-manufacturing-online.co.uk/category/news/
